Catholic supreme » Promising new treatment option for women with …
Combining the new decorous trabectedin with pegylated liposomal doxorubicin provides clinical profit to women with relapsed ovarian cancer , according to renewed results presented at the 33rd Congress of the European Society to Medical Oncology (ESMO) in Stockholm. … ovarian cancer . Trabectedin, a synthetic version of a compound first isolated from sea-squirts, has been granted marketing approval in Europe for the treatment of patients with advanced soft tissue sarcoma . …
Here is the original:
Catholic supreme Promising new treatment option for women with …
Stumble Upon
Del.icio.us
Buzz
